Quantbot Technologies LP Adicet Bio, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.11 - $1.89 $666 - $1,134	-600 Reduced 9.84%	5,500 $10,000
Q3 2023 Nov 07, 2023	SELL	$1.37 - $3.4 $8,220 - $20,400	-6,000 Reduced 49.59%	6,100 $8,000
Q2 2023 Aug 08, 2023	SELL	$2.13 - $7.13 $5,751 - $19,251	-2,700 Reduced 18.24%	12,100 $29,000
Q1 2023 May 12, 2023	BUY	$5.52 - $9.23 $81,696 - $136,604	14,800 New	14,800 $85,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.